Copy variations in schizophrenia and bipolar disorder

Cytogenetic and Genome Research

Volumn 123, Issue 1-4, 2009, Pages 27-35

  Lachman, H M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIPOLAR DISORDER; CHROMOSOME TRANSLOCATION; DISC1 GENE; DNA DETERMINATION; GENE; GENE DISRUPTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

ANIMALS; BIPOLAR DISORDER; GENE DOSAGE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; SCHIZOPHRENIA;

EID: 62549129539     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000184689     Document Type: Review

References (94)

1. Alarcon M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, et al: Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 82:150-159 (2008).
2. Arenzana-Seisdedos F, Parmentier M: Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. Semin Immunol 18:387-403 (2006).
3. Arking DE, Cutler DJ, Brune CW, Teslovich TM, West K, et al: A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 82:160-164 (2008).
4. Barrett TB, Emberton JE, Nievergelt CM, Liang SG, Hauger RL, et al: Further evidence for association of GRK3 to bipolar disorder suggests a second disease mutation. Psychiatr Genet 17:315-322 (2007).
5. Bassett AS, Chow EW: Schizophrenia and 22q11.2 deletion syndrome. Curr Psychiatry Rep 10:148-157 (2008).
6. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, et al: A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197-207 (2008).
7. Berridge MJ, Irvine RF: Inositol phosphates and cell signalling. Nature 341:197-205 (1989).
8. Biederer T, Sudhof TC: Mints as adaptors. Direct binding to neurexins and recruitment of munc18. J Biol Chem 275:39803-39806 (2000).
9. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, et al: Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16:24-35 (2007).
10. Brandon NJ: Dissecting DISC1 function through protein-protein interactions. Biochem Soc Trans 35:1283-1286 (2007).
11. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, et al: Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci USA 102:8627-8632 (2005).
12. Cantor RM, Geschwind DH: Schizophrenia: genome, interrupted. Neuron 58:165-167 (2008).
13. Carlson C, Papolos D, Pandita RK, Faedda GL, Veit S, et al: Molecular analysis of velo-cardio-facial syndrome patients with psychiatric disorders. Am J Hum Genet 60:851-859 (1997).
14. Chen J, Lipska BK, Weinberger DR: Genetic mouse models of schizophrenia: From hypothesisbased to susceptibility gene-based models. Biol Psychiatry 59:1180-1188 (2006).
15. Craddock N, O'Donovan MC, Owen MJ: The genetics of schizophrenia and bipolar disorder: Dissecting psychosis. J Med Genet 42:193-204 (2005).
16. Craig AM, Kang Y: Neurexin-neuroligin signaling in synapse development. Curr Opin Neurobiol 17:43-52 (2007).
17. Davies W, Isles AR, Humby T, Wilkinson LS: What are imprinted genes doing in the brain? Adv Exp Med Biol 626:62-70 (2008).
18. Ekelund J, Hovatta I, Parker A, Paunio T, Varilo T, et al: Chromosome 1 loci in Finnish schizophrenia families. Hum Mol Genet 10:1611-1617 (2001).
19. Ekelund J, Hennah W, Hiekkalinna T, Parker A, Meyer J, Lonnqvist J, Peltonen L: Replication of 1q42 linkage in Finnish schizophrenia pedigrees. Mol Psychiatry 9:1037-1041 (2004).
20. Estivill X, Armengol L: Copy number variants and common disorders: Filling the gaps and exploring complexity in genome-wide association studies. PLoS Genet 3:1787-1799 (2007).
21. Feuk L, Marshall CR, Wintle RF, Scherer SW: Structural variants: Changing the landscape of chromosomes and design of disease studies. Hum Mol Genet 15 Spec No 1:R57-66 (2006).
22. Flomen RH, Collier DA, Osborne S, Munro J, Breen G, et al: Association study of CHRFAM7A copy number and 2 bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 141:571-575 (2006).
23. Friedman JI, Vrijenhoek T, Markx S, Janssen IM, van der Vliet WA, et al: CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy. Mol Psychiatry 13:261-266 (2008).
24. Georgieva L, Dimitrova A, Ivanov D, Nikolov I, Williams NM, et al: Support for neuregulin 1 as a susceptibility gene for bipolar disorder and schizophrenia. Biol Psychiatry 64:419-427 (2008).
25. Goidts V, Cooper DN, Armengol L, Schempp W, Conroy J, et al: Complex patterns of copy number variation at sites of segmental duplications: An important category of structural variation in the human genome. Hum Genet 120:270-284 (2006).
26. Gould TD, Picchini AM, Einat H, Manji HK: Targeting glycogen synthase kinase-3 in the CNS: Implications for the development of new treatments for mood disorders. Curr Drug Targets 7:1399-1409 (2006).
27. Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM: Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119:1013-1026 (2004).
28. Hamshere ML, Bennett P, Williams N, Segurado R, Cardno A, et al: Genomewide linkage scan in schizoaffective disorder: Significant evidence for linkage at 1q42 close to DISC1, and suggestive evidence at 22q11 and 19p13. Arch Gen Psychiatry 62:1081-1088 (2005).
29. Harrison PJ, Weinberger DR: Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:40-68; image 5 (2005).
30. Hishimoto A, Liu QR, Drgon T, Pletnikova O, Walther D, et al: Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum Mol Genet 16:2880-2891 (2007).
31. Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, et al: Detection of large-scale variation in the human genome. Nat Genet 36:949-951 (2004).
32. Iossifov I, Zheng T, Baron M, Gilliam TC, Rzhetsky A: Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network. Genome Res 18:1150-1162 (2008).
33. James R, Adams RR, Christie S, Buchanan SR, Porteous DJ, Millar JK: Disrupted in schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci 26:112-122 (2004).
34. Johnston CM, Lovell FL, Leongamornlert DA, Stranger BE, Dermitzakis ET, Ross MT: Large-scale population study of human cell lines indicates that dosage compensation is virtually complete. PLoS Genet 4:e9 (2008).
35. Kamiya A, Tomoda T, Chang J, Takaki M, Zhan C, et al: DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1. Hum Mol Genet 15:3313-3323 (2006).
36. Kaneko R, Kato H, Kawamura Y, Esumi S, Hirayama T, et al: Allelic gene regulation of Pcdh-alpha and Pcdh -gamma clusters involving both monoallelic and biallelic expression in single Purkinje cells. J Biol Chem 281:30551-30560 (2006).
37. Kang Y, Zhang X, Dobie F, Wu H, Craig AM: Induction of GABAergic postsynaptic differentiation by alpha-neurexins. J Biol Chem 283:2323-2334 (2008).
38. Karayiorgou M, Gogos JA: The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 132:95-104 (2004).
39. Kato T: Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 61:3-19 (2007).
40. Kehrer-Sawatzki H: What a difference copy number variation makes. Bioessays 29:311-313 (2007).
41. Kelsey G: Genomic imprinting - roles and regulation in development. Endocr Dev 12:99-112 (2007).
42. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, et al: Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 82:199-207 (2008).
43. Kirov G, Gumus D, Chen W, Norton N, Georgieva L, et al: Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 17:458-465 (2008a).
44. Kirov G, Zaharieva I, Georgieva L, Moskvina V, Nikolov I, et al: A genome-wide association study in 574 schizophrenia trios using DNA pooling. Mol Psychiatry, Epub ahead of print (2008b).
45. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM: Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250 (1996).
46. Lachman HM, Pedrosa E, Nolan KA, Glass M, Ye K, Saito T: Analysis of polymorphisms in AT-rich domains of neuregulin 1 gene in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 141:102-109 (2006).
47. Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, et al: Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144:259-265 (2007a).
48. Lachman HM, Fann CS, Bartzis M, Evgrafov OV, Rosenthal RN, et al: Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet 16:1327-1334 (2007b).
49. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, et al: X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74: 552-557 (2004).
50. Lawson-Yuen A, Saldivar JS, Sommer S, Picker J: Familial deletion within NLGN4 associated with autism and Tourette syndrome. Eur J Hum Genet 16:614-618 (2008).
51. Lemon B, Tjian R: Orchestrated response: A symphony of transcription factors for gene control. Genes Dev 14:2551-2569 (2000).
52. Lewis DA, Lieberman JA: Catching up on schizophrenia: Natural history and neurobiology. Neuron 28:325-334 (2000).
53. Li C, Wu Q: Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes. BMC Evol Biol 7:69 (2007).
54. Lise MF, El-Husseini A: The neuroligin and neurexin families: From structure to function at the synapse. Cell Mol Life Sci 63:1833-1849 (2006).
55. McCarroll SA, Altshuler DM: Copy-number variation and association studies of human disease. Nat Genet 39:S37-42 (2007).
56. Millar JK, Pickard BS, Mackie S, James R, Christie S, et al: DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310:1187-1191 (2005).
57. Moon HJ, Yim SV, Lee WK, Jeon YW, Kim YH, et al: Identification of DNA copy-number aberrations by array-comparative genomic hybridization in patients with schizophrenia. Biochem Biophys Res Commun 344: 531-539 (2006).
58. Mori A, Okuyama K, Horie M, Taniguchi Y, Wadatsu T, et al: Alteration of methamphetamine-induced striatal dopamine release in mint-1 knockout mice. Neurosci Res 43:251-257 (2002).
59. Murphy KC: Schizophrenia and velo-cardio-facial syndrome. Lancet 359:426-430 (2002).
60. Ng K, Pullirsch D, Leeb M, Wutz A: Xist and the order of silencing. EMBO Rep 8:34-39 (2007).
61. Nguyen DQ, Webber C, Ponting CP: Bias of selection on human copy-number variants. PLoS Genet 2:e20 (2006).
62. Nielsen KB, Sorensen S, Cartegni L, Corydon TJ, Doktor TK, et al: Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: A synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet 80:416-432 (2007).
63. Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J, Li MD: Significant association of the neurexin 1 gene ( NRXN1) with nicotine dependence in European- and African-American smokers. Hum Mol Genet 17:1569-1577 (2008).
64. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM: Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-O-methyltransferase allele. Mol Psychiatry 3:346-349 (1998).
65. Paterlini M, Zakharenko SS, Lai WS, Qin J, Zhang H, et al: Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat Neurosci 8:1586-1594 (2005).
66. Pinkel D, Albertson DG: Comparative genomic hybridization. Annu Rev Genomics Hum Genet 6:331-354 (2005).
67. Pinto D, Marshall C, Feuk L, Scherer SW: Copynumber variation in control population cohorts. Hum Mol Genet 16 Spec No. 2:R168-173 (2007).
68. Qu HQ, Lawrence SG, Guo F, Majewski J, Polychronakos C: Strand bias in complementary single-nucleotide polymorphisms of transcribed human sequences: Evidence for functional effects of synonymous polymorphisms. BMC Genomics 7:213 (2006).
69. Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, et al: Global variation in copy number in the human genome. Nature 444:444-454 (2006).
70. Ribich S, Tasic B, Maniatis T: Identification of long-range regulatory elements in the protocadherin-alpha gene cluster. Proc Natl Acad Sci USA 103:19719-19724 (2006).
71. Ross CA, Margolis RL, Reading SA, Pletnikov M, Coyle JT: Neurobiology of schizophrenia. Neuron 52:139-153 (2006).
72. Rowen L, Young J, Birditt B, Kaur A, Madan A, et al: Analysis of the human neurexin genes: Alternative splicing and the generation of protein diversity. Genomics 79:587-597 (2002).
73. Sebat J, Lakshmi B, Troge J, Alexander J, Young J, et al: Large-scale copy number polymorphism in the human genome. Science 305:525-528 (2004).
74. Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, et al: Whole-genome association study of bipolar disorder. Mol Psychiatry 13:558-569 (2008).
75. Smoller JW, Gardner-Schuster E: Genetics of bipolar disorder. Curr Psychiatry Rep 9:504-511 (2007).
76. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, et al: Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336:13-16 (1990).
77. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, et al: Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 71:877-892 (2002).
78. Stefansson H, Steinthorsdottir V, Thorgeirsson TE, Gulcher JR, Stefansson K: Neuregulin 1 and schizophrenia. Ann Med 36:62-71 (2004).
79. Stefansson H, Rujescu D, Cichon S, Pietiläinen OP, Ingason A, Steinberg S, et al. Large recurrent microdeletions associated with schizophrenia. Nature 455:232-236 (2008).
80. Straub RE, Weinberger DR: Schizophrenia genes - famine to feast. Biol Psychiatry 60:81-83 (2006).
81. Sun J, Kuo PH, Riley BP, Kendler KS, Zhao Z: Candidate genes for schizophrenia: A survey of association studies and gene ranking. Am J Med Genet B Neuropsychiatr Genet 147B:1173-1181 (2008).
82. Sutrala SR, Norton N, Williams NM, Buckland PR: Gene copy number variation in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 147B:606-611 (2007).
83. Tabuchi K, Sudhof TC: Structure and evolution of neurexin genes: Insight into the mechanism of alternative splicing. Genomics 79:849-859 (2002).
84. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM, Sudhof TC: A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318:71-76 (2007).
85. Taya S, Shinoda T, Tsuboi D, Asaki J, Nagai K, et al: DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 27:15-26 (2007).
86. The International Schizophrenia Consortium. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455:237-241 (2008).
87. Thomson PA, Christoforou A, Morris SW, Adie E, Pickard BS, et al: Association of neuregulin 1 with schizophrenia and bipolar disorder in a second cohort from the Scottish population. Mol Psychiatry 12:94-104 (2007).
88. Ushkaryov YA, Sudhof TC: Neurexin III alpha: Extensive alternative splicing generates membrane-bound and soluble forms. Proc Natl Acad Sci USA 90:6410-6414 (1993).
89. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, et al: Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320:539-543 (2008).
90. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447:661-678 (2007).
91. West AG, Fraser P: Remote control of gene transcription. Hum Mol Genet 14 Spec No 1:R101-111 (2005).
92. Williams TN: Human red blood cell polymorphisms and malaria. Curr Opin Microbiol 9:388-394 (2006).
93. Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA: DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum Mol Genet 15:743-749 (2006).
94. Zanger UM, Klein K, Saussele T, Blievernicht J, Hofmann MH, Schwab M: Polymorphic CYP2B6: Molecular mechanisms and emerging clinical significance. Pharmacogenomics 8:743-759 (2007).